Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439017
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-27
Brief Title:
Passive Thoughts in Functional Movement Disorders
Sponsor:
Western University
Organization:
Western University
Study Overview
Official Title:
Passive Thoughts in Functional Movement Disorders
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Passive thoughts also known as mind-wandering are the thoughts that are not produced from the current task When we arent focused on a task that needs our full attention our minds tend to drift from one thought to another It is believed that mind wandering is the baseline or natural state of the mind and we shift our focus only when needed for a task Many areas of the brain are active during mind-wandering and these areas together are called the brains default network An important part of this network is the right temporoparietal junction
Functional movement disorder FMD is characterized by unusual movements or walking difficulties that are not caused by a specific brain or nerve injury Functional movement disorders are believed to be caused due to loss of sense of agency The sense of agency is the awareness that one is responsible for their own actions The brain network involved in the sense of agency is mainly located in the right side of the brain especially in the right temporoparietal junction In FMD patients there is decreased connectivity between the right temporoparietal junction and other brain areas that control movement
Since both passive thoughts mind wandering and the sense of agency involve the temporoparietal junction and because the sense of agency is abnormal in functional movement disorders FMD we plan to study passive thoughts in individuals with FMD The study aims to find out how passive thoughts differ between individuals with FMD and healthy individuals Passive thoughts will be measured using Mind Excessively Wandering Scale MEWS
Functional movement disorder FMD is characterized by unusual movements or walking difficulties that are not caused by a specific brain or nerve injury Functional movement disorders are believed to be caused due to loss of sense of agency The sense of agency is the awareness that one is responsible for their own actions The brain network involved in the sense of agency is mainly located in the right side of the brain especially in the right temporoparietal junction In FMD patients there is decreased connectivity between the right temporoparietal junction and other brain areas that control movement
Since both passive thoughts mind wandering and the sense of agency involve the temporoparietal junction and because the sense of agency is abnormal in functional movement disorders FMD we plan to study passive thoughts in individuals with FMD The study aims to find out how passive thoughts differ between individuals with FMD and healthy individuals Passive thoughts will be measured using Mind Excessively Wandering Scale MEWS
Detailed Description:
To evaluate passive thoughts in functional movement disorders FMD we will collect data from 30 FMD patients and 30 healthy controls Patients will be recruited from the movement disorders clinic and the integrated functional movement disorders clinic at LHSC Both groups will be asked to complete the paper-based Mind Excessively Wandering Scale MEWS to evaluate passive thoughts Additionally FMD patients will complete the World Health Organization Disability Assessment Schedule 20 WHODAS 20 a 36-item self-administered questionnaire designed to measure disability over the past 30 days Completing both questionnaires will take approximately 15-20 minutes The questionnaires will be completed once
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None